A detailed history of Ubs Group Ag transactions in Inari Medical, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 80,469 shares of NARI stock, worth $4.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80,469
Previous 22,425 258.84%
Holding current value
$4.26 Million
Previous $1.08 Million 207.41%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$40.68 - $58.62 $2.36 Million - $3.4 Million
58,044 Added 258.84%
80,469 $3.32 Million
Q2 2024

Aug 13, 2024

SELL
$37.11 - $50.69 $500,947 - $684,264
-13,499 Reduced 37.58%
22,425 $1.08 Million
Q1 2024

May 13, 2024

SELL
$40.65 - $65.76 $342,151 - $553,501
-8,417 Reduced 18.98%
35,924 $1.72 Million
Q4 2023

Feb 09, 2024

BUY
$48.3 - $68.06 $1.04 Million - $1.46 Million
21,444 Added 93.65%
44,341 $2.88 Million
Q3 2023

Nov 09, 2023

SELL
$54.2 - $71.67 $1.42 Million - $1.87 Million
-26,108 Reduced 53.28%
22,897 $1.5 Million
Q2 2023

Aug 11, 2023

BUY
$56.23 - $71.17 $1.27 Million - $1.61 Million
22,625 Added 85.77%
49,005 $2.85 Million
Q1 2023

May 12, 2023

BUY
$53.43 - $68.12 $429,630 - $547,752
8,041 Added 43.85%
26,380 $1.63 Million
Q4 2022

Feb 08, 2023

BUY
$61.23 - $83.62 $912,082 - $1.25 Million
14,896 Added 432.65%
18,339 $1.17 Million
Q3 2022

Nov 10, 2022

BUY
$65.58 - $84.69 $8,328 - $10,755
127 Added 3.83%
3,443 $250,000
Q2 2022

Aug 10, 2022

SELL
$52.13 - $93.81 $242,143 - $435,747
-4,645 Reduced 58.35%
3,316 $225,000
Q1 2022

May 16, 2022

SELL
$64.92 - $99.47 $378,418 - $579,810
-5,829 Reduced 42.27%
7,961 $722,000
Q4 2021

Feb 14, 2022

BUY
$76.51 - $93.96 $811,694 - $996,821
10,609 Added 333.51%
13,790 $1.26 Million
Q3 2021

Nov 15, 2021

BUY
$71.29 - $95.99 $168,529 - $226,920
2,364 Added 289.35%
3,181 $258,000
Q2 2021

Aug 13, 2021

SELL
$79.62 - $114.85 $384,723 - $554,955
-4,832 Reduced 85.54%
817 $76,000
Q1 2021

May 12, 2021

BUY
$77.91 - $125.92 $310,159 - $501,287
3,981 Added 238.67%
5,649 $605,000
Q4 2020

Feb 11, 2021

BUY
$60.0 - $87.29 $62,400 - $90,781
1,040 Added 165.61%
1,668 $145,000
Q3 2020

Nov 12, 2020

SELL
$47.53 - $82.76 $10,361 - $18,041
-218 Reduced 25.77%
628 $43,000
Q2 2020

Jul 31, 2020

BUY
$42.51 - $52.46 $35,963 - $44,381
846 New
846 $41,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.83B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.